CompoAtlas

Huile essentielle de Camomille noble

Food supplement declared in France, declaration No 2020-10-867, decision dated 20 October 2020

Huile essentielle de Camomille noble (Obisol) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Chamaemelum nobile 150 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
Obisol
Food business operator placing the product on the market
NEXARIAN FRANCE
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Dropper
Daily dose
150mg
Directions for use
Ingestion sur un support neutre
Not recommended (according to the manufacturer)
Breastfeeding women, Young children (aged 1 to 3), Pregnant women
Objectives stated by the manufacturer (these are not authorised claims)
Sleep, Mood, Nervous system

Declaration 317371, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Chamaemelum nobile (L.) All.Essence (flowering tops)Distillation150 mg

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Complément Alimentaire Les compléments alimentaires ne sont pas un substitut à un régime sain et varié. Conseils d'utilisations: Ingérer 2 gouttes 3 fois/jour sur un support neutre (150mg.). Ne pas utiliser pendant la grossesse et l'allaitement, ni chez l'enfant de moins de 6 ans. Ne pas dépasser la dose conseillée. Tenir hors de portée des jeunes enfants.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Chamaemelum nobile (L.) All.
    Read the warning, when it applies and the studies cited

    Roman Chamomile - Chamaemelum Nobile

    Route of administration: Oral (Wichtl 2004; Bradley 1992)

    Cautions and warnings

    Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010; Mills and Bone 2000; Blumenthal et al. 1998).

    Sources cited by Health Canada (3)
    • Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW, Rister RS, editors. Herbal Medicine: Complete Commission E Monographs. Boston (MA): Integrative Medicine Communications; 1998.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.

    Health Canada monograph dated 27 March 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : Obisol

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Huile essentielle de Camomille noble (Obisol): composition and regulation”, https://compoatlas.com/en/supplements/products/317371-huile-essentielle-de-camomille-noble, updated 15 November 2026.

List recorded in 2020. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line